全文获取类型
收费全文 | 2678篇 |
免费 | 157篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 64篇 |
妇产科学 | 80篇 |
基础医学 | 401篇 |
口腔科学 | 83篇 |
临床医学 | 193篇 |
内科学 | 578篇 |
皮肤病学 | 52篇 |
神经病学 | 229篇 |
特种医学 | 83篇 |
外科学 | 482篇 |
综合类 | 16篇 |
预防医学 | 88篇 |
眼科学 | 59篇 |
药学 | 166篇 |
中国医学 | 9篇 |
肿瘤学 | 251篇 |
出版年
2023年 | 15篇 |
2022年 | 28篇 |
2021年 | 55篇 |
2020年 | 40篇 |
2019年 | 61篇 |
2018年 | 68篇 |
2017年 | 43篇 |
2016年 | 46篇 |
2015年 | 56篇 |
2014年 | 90篇 |
2013年 | 127篇 |
2012年 | 156篇 |
2011年 | 195篇 |
2010年 | 92篇 |
2009年 | 116篇 |
2008年 | 155篇 |
2007年 | 153篇 |
2006年 | 155篇 |
2005年 | 133篇 |
2004年 | 147篇 |
2003年 | 117篇 |
2002年 | 124篇 |
2001年 | 97篇 |
2000年 | 63篇 |
1999年 | 73篇 |
1998年 | 19篇 |
1997年 | 19篇 |
1996年 | 18篇 |
1995年 | 20篇 |
1994年 | 20篇 |
1993年 | 11篇 |
1992年 | 36篇 |
1991年 | 23篇 |
1990年 | 40篇 |
1989年 | 41篇 |
1988年 | 21篇 |
1987年 | 24篇 |
1986年 | 16篇 |
1985年 | 18篇 |
1984年 | 11篇 |
1983年 | 6篇 |
1982年 | 8篇 |
1980年 | 6篇 |
1977年 | 5篇 |
1976年 | 5篇 |
1974年 | 8篇 |
1973年 | 6篇 |
1970年 | 8篇 |
1967年 | 5篇 |
1966年 | 5篇 |
排序方式: 共有2840条查询结果,搜索用时 15 毫秒
101.
Type 2 diabetes mellitus(T2DM) is a lifelong condition and a grave threat to human health. Innovative efforts to relieve its detrimental effects are acutely needed. The sine qua non in T2DM management is consistent adherence to a prudent lifestyle and nutrition, combined with aerobic and resistance exercise regimens, together repeatedly shown to lead to complete reversal and even longterm remission. Non-adherence to the above lifestyle adjustments condemns any treatment effort and ultimately the... 相似文献
102.
Cognitive and cerebrovascular deficits are 2 landmarks of Alzheimer's disease (AD) to target for effective therapy. Here, we evaluated the efficacy of simvastatin in bitransgenic A/T mice overexpressing a mutated form of the human amyloid precursor protein (APPSwe,Ind) and a constitutively active form of transforming growth factor-β1. These mice feature the AD amyloid beta (Aβ) and cerebrovascular pathology. Simvastatin significantly decreased insoluble Aβ peptide levels and Aβ plaque load despite no effect on β-site amyloid precursor protein-cleaving enzyme and Aβ-degrading enzyme neprilysin protein levels. However, simvastatin failed to improve spatial learning and memory deficits and the decreased baseline levels of the memory-related protein early growth response-1 (Egr-1) in the hippocampus CA1 area. The impaired hyperemic response to whisker stimulation in A/T mice was not improved with treatment, but simvastatin fully restored constitutive nitric oxide synthesis in vessel walls and exacerbated agonist-mediated dilatory deficits. These findings point to the efficacy of simvastatin on selective AD features in a complex model of the disease, likely reflecting the challenges faced by recent clinical trials in assessing statin efficacy. 相似文献
103.
C. Pitsios P. Demoly M. B. Bilò R. Gerth van Wijk O. Pfaar G. J. Sturm P. Rodriguez del Rio M. Tsoumani R. Gawlik G. Paraskevopoulos F. Ruëff E. Valovirta N. G. Papadopoulos M. A. Calderón 《Allergy》2015,70(8):897-909
Clinical indications for allergen immunotherapy (AIT) in respiratory and Hymenoptera venom allergy are well established; however, clinical contraindications to AIT are not always well documented. There are some discrepancies when classifying clinical contraindications for different forms of AIT as ‘absolute’ or ‘relative’. EAACI Task Force on ‘Contraindications to AIT’ was created to evaluate and review current literature on clinical contraindications, and to update recommendations for both sublingual and subcutaneous AIT for respiratory and venom immunotherapy. An extensive review of the literature was performed on the use of AIT in asthma, autoimmune disorders, malignant neoplasias, cardiovascular diseases, acquired immunodeficiencies and other chronic diseases (including mental disorders), in patients treated with β‐blockers, ACE inhibitors or monoamine oxidase inhibitors, in children under 5 years of age, during pregnancy and in patients with poor compliance. Each topic was addressed by the following three questions: (1) Are there any negative effects of AIT on this concomitant condition/disease? (2) Are more frequent or more severe AIT‐related side‐effects expected? and (3) Is AIT expected to be less efficacious? The evidence, for the evaluation of these clinical conditions as contraindications, was limited, and most of the conclusions were based on case reports. Based on an extended literature research, recommendations for each medical condition assessed are provided. The final decision on the administration of AIT should be based on individual evaluation of any medical condition and a risk/benefit assessment for each patient. 相似文献
104.
Stough C Downey LA Lloyd J Silber B Redman S Hutchison C Wesnes K Nathan PJ 《Phytotherapy research : PTR》2008,22(12):1629-1634
While Ayurvedic medicine has touted the cognitive enhancing effects of Bacopa monniera for centuries, there is a need for double-blind placebo-controlled investigations. One hundred and seven healthy participants were recruited for this double-blind placebo-controlled independent group design investigation. Sixty-two participants completed the study with 80% treatment compliance. Neuropsychological testing using the Cognitive Drug Research cognitive assessment system was conducted at baseline and after 90 days of treatment with a special extract of Bacopa monniera (2 x 150 mg KeenMind) or placebo. The Bacopa monniera product significantly improved performance on the 'Working Memory' factor, more specifically spatial working memory accuracy. The number of false-positives recorded in the Rapid visual information processing task was also reduced for the Bacopa monniera group following the treatment period. The current study provides support for the two other published studies reporting cognitive enhancing effects in healthy humans after a 90 day administration of the Bacopa monniera extract. Further studies are required to ascertain the effective dosage range, the time required to attain therapeutic levels and the effects over a longer term of administration. 相似文献
105.
Matsagas MI Fatouros M Mitsis M Bali C Papadopoulos G Kappas AM 《Annals of vascular surgery》2004,18(3):361-364
Conventional treatment of an infected aortobifemoral graft includes total graft excision and ex situ bypass grafting, but has been associated with significant perioperative morbidity and mortality. Additionally, the presence of infection in the groin makes limb revascularization problematic. There is increasing evidence that in situ replacement of an infected graft can achieve promising results in selected patients. We present a case of an aortobifemoral graft infection, affecting both the groin as well as the entire pelvis. The patient underwent successful in situ graft replacement with a new aortobipopliteal prosthesis via an alternative extraperitoneal route. 相似文献
106.
107.
C. L. Skevaki I. Christodoulou I. S. Spyridaki I. Tiniakou V. Georgiou P. Xepapadaki D. A. Kafetzis N. G. Papadopoulos 《Clinical and experimental allergy》2009,39(11):1700-1710
Background Rhinoviruses (RVs) are responsible for the majority of acute asthma and chronic obstructive pulmonary disease (COPD) exacerbations. RVs infect the lower airways and induce the production of pro-inflammatory and remodelling-associated mediators. Budesonide (BUD) and formoterol (FORM) synergize in controlling asthma and COPD exacerbations; however, their effects on virus-induced inflammation and remodelling are less known.
Objective We investigated whether BUD and FORM synergize in suppressing RV-induced inflammation and remodelling in the airways.
Methods In vitro models of RV infection of BEAS-2B and primary normal human bronchial epithelial (NHBE) cells were used. We assessed the effects of individual and combined drugs administered post-infection, at a clinically relevant concentration range (10−6 –10−10 m ), on the production of CCL5, CXCL10, CXCL8, IL-6 and the remodelling-associated VEGF and bFGF, using ELISA and RT-PCR.
Results BUD effectively suppressed RV-mediated induction of all mediators studied, in a concentration-dependent manner. FORM alone suppressed the production of CXCL8 and bFGF. The combination of BUD and FORM had concentration-dependent, additive or synergistic effects in the suppression of RV-induced CCL5, CXCL8 and CXCL10 in both cell types as well as VEGF in NHBE only. Combination treatment also resulted in an enhanced suppression of RV-induced IL-6, and CCL5 at the mRNA level as compared with BUD or FORM alone.
Conclusion BUD and FORM suppress RV-induced chemokines and growth factors in bronchial epithelial cells in a concentration-dependent, synergistic or additive manner. These data further support the combined use of BUD and FORM in asthma and COPD and intensification of this therapy during exacerbations. 相似文献
Objective We investigated whether BUD and FORM synergize in suppressing RV-induced inflammation and remodelling in the airways.
Methods In vitro models of RV infection of BEAS-2B and primary normal human bronchial epithelial (NHBE) cells were used. We assessed the effects of individual and combined drugs administered post-infection, at a clinically relevant concentration range (10
Results BUD effectively suppressed RV-mediated induction of all mediators studied, in a concentration-dependent manner. FORM alone suppressed the production of CXCL8 and bFGF. The combination of BUD and FORM had concentration-dependent, additive or synergistic effects in the suppression of RV-induced CCL5, CXCL8 and CXCL10 in both cell types as well as VEGF in NHBE only. Combination treatment also resulted in an enhanced suppression of RV-induced IL-6, and CCL5 at the mRNA level as compared with BUD or FORM alone.
Conclusion BUD and FORM suppress RV-induced chemokines and growth factors in bronchial epithelial cells in a concentration-dependent, synergistic or additive manner. These data further support the combined use of BUD and FORM in asthma and COPD and intensification of this therapy during exacerbations. 相似文献
108.
Georgios Papadopoulos Nikolaos G Baikoussis Petros Tzimas Stavros N Siminelakis Menelaos Karanikolas 《Journal of cardiothoracic surgery》2010,5(1):9
This the case of a 63 year-old man with end-stage renal disease (on chronic hemodialysis), unstable angina and significantly
impaired myocardial contractility with low left ventricular ejection fraction, who underwent off-pump one vessel coronary
bypass surgery. Combined continuous levosimendan and norepinephrine infusion (at 0.07 μg/kg/min and 0.05 μg/kg/min respectively)
started immediately after anesthesia induction and continued for 24 hours. The levosimendan/norepinephrine combination helped
maintain an appropriate hemodynamic profile, thereby contributing to uneventful completion of surgery and postoperative hemodynamic
stability. Although levosimendan is considered contraindicated in ESRD patients, this case report suggests that combined perioperative
levosimendan/norepinephrine administration can be useful in carefully selected hemodialysis patients with impaired myocardial
contractility and ongoing myocardial ischemia, who undergo off-pump myocardial revascularization surgery. 相似文献
109.
110.
B D Thanopoulos A Margetakis G Papadopoulos E Kefalakis S Rokas 《Acta paediatrica Scandinavica》1989,78(5):742-746
Percutaneous balloon valvuloplasty was performed in 16 children, 1 1/2 to 14 years old, with congenital pulmonary stenosis with teh use or trefoil balloons. These balloons, which consist of 3 identical angioplasty balloons, do not interrupt completely the blood flow during inflation. The size of the trefoil balloons used was 30 to 50% larger than the valve anulus. A obtain an effective pulmonary valvuloplasty in two patients with large valve anulus. The mean prevalvuloplasty systolic gradient fo 78.2 +/- 28.9 mmHg (range 40 to 140 mmHg) was reduced to 20.3 +/- 5.7 (range 10 to 30 mmHg) after valvuloplasty. No patient developed significant hypotension or bradycardia or other complications as a result of the procedure. The findings demonstrate that percutaneous balloon valvuloplasty with oversized trefoil balloons effectively treated congenital pulmonary stenosis without complications in the cases studied. The use of large trefoil instead of single balloons of a similar diameter is advantageous since they cause no significant compromise of the cardiac output during valvuloplasty. 相似文献